PAK1 and cancer: Their centralised roles in numerous oncogenic signalling pathways and frequent overexpression and/ or amplification in human cancers, notably PAK1 and PAK4 in BCa, lend themselves as ideal therapeutic candidates (King et al., 2014, Rane and Minden, 2019).